Genentech - A Member of the Roche Group

/ Scientists

Focus on Infectious Disease

Recently, we've seen an explosion of new information about the basic biology of pathogens and how a host responds to infection. We're using this new information to develop new medicines and technologies that combat serious bacterial and viral infections, such as HCV.

In the department of microbial pathogenesis we're focused on understanding the molecular mechanisms of disease and developing of novel technologies to interrupt pathogenic events. We're also exploring new ways to deliver therapeutics to the site of infection, that are both more efficient at pathogen elimination and less toxic to the host.

Recent Publications

PLoS Pathogens, March 2012
Influenza a virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.
View Article

PLoS Pathogens, May 2009
Atg5-independent sequestration of ubiquitinated mycobacteria.
View Article